Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
Massachusetts General Hospital · Memorial Sloan Kettering Cancer Center · +15 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,299
total citations
- FWCI
- 105.49
- Percentile
- 100%
- References
- 44
Citations per year
Authors
22- JSJeremy S AbramsonCorresponding
Massachusetts General Hospital
- MLM. Lia Palomba
Memorial Sloan Kettering Cancer Center
- LILeo I. Gordon
Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- MAMatthew A. Lunning
University of Nebraska Medical Center
- MWMichael Wang
The University of Texas MD Anderson Cancer Center
Topics & keywords
Topics
Keywords
- Refractory (planetary science)
- Medicine
- Internal medicine
- Oncology
- Lymphoma
- Biology
UN Sustainable Development Goals
- Life below water
No related works found for this paper.